Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

hydrocortisone sodium succinate/aluminum phosphate gel

A gel composed of the sodium succinate form of the glucocorticoid hydrocortisone mixed with aluminum phosphate, with potential protective activity. Upon oral administration of the hydrocortisone sodium succinate/aluminum phosphate gel, the gel forms a layer over the esophageal mucosa, which may restore and protect the esophageal membrane against damage. Hydrocortisone exerts anti-inflammatory effects locally, may reduce or prevent infection, may reduce the formation of connective tissue in order to prevent postoperative esophageal stenosis and stricture, and may reduce symptoms of dysphagia or choking, after endoscopic submucosal dissection (ESD). The aluminum phosphate acts as a buffer and may protect the local mucosal membrane from the acidic environment.
Synonym:hydrocortisone sodium succinate mixed with aluminum phosphate gel
Search NCI's Drug Dictionary